<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04095377</url>
  </required_header>
  <id_info>
    <org_study_id>0292-18</org_study_id>
    <nct_id>NCT04095377</nct_id>
  </id_info>
  <brief_title>Development of Automated Analysis to Electroencephelogram (EEG) Data in Patients Treated at the Sagol Hyperbaric Medicine and Research Center at the Years 2017-2019.</brief_title>
  <official_title>Development of Automated Analysis to Electroencephelogram (EEG) Data in Patients Treated at the Sagol Hyperbaric Medicine and Research Center at the Years 2017-2019 - A Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>QuantalX Neuroscience</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>QuantalX Neuroscience</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      DELPhI software developed for the analysis of EEG recordings in response to magnetic
      stimulation in relation to clinical data.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Collection of EEG data, recorded at Sagol center for hyperbaric medicine and research in the
      years of 2017-2019 of patients arriving to be treated at the hyperbaric chamber before,during
      and after treatments. EEG was recorded of patients during cognitive tests, resting state and
      during magnetic stimulation as a part of other array of tests performed at the Sagol center.
      Anonymous EEG data along with MRI scans, PET-CT, SPECT, cognitive tests, Medical history and
      medications will be transferred to QuantalX Neuroscience LTD.

      QuantalX Neuroscience is intending to use the above mentioned data in order to improve
      DELPhI, an algorithm for the analysis of EEG recordings in response to magnetic stimulation.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 24, 2019</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Defining Plasticity (the ratio between excitatory to inhibitory brain response) Means and STD in each cohort.</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Measure of the mean and STD Plasticity of each cohort.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Defining Connectivity (dispersion of brain signal) Means and STD in each cohort.</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Measure of the mean and STD Connectivity of each cohort.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Defining Plasticity (the ratio between excitatory to inhibitory brain response) standard error (SEM) in each cohort.</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Measure of the standard error (SEM) of Plasticity of each cohort.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Defining Connectivity (dispersion of brain signal) standard error (SEM) in each cohort.</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Measure of the standard error (SEM) of Connectivity of each cohort.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Defining Plasticity (excitation/inhibition brain response) coefficient of variation (CV%) in each cohort.</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Measure of the coefficient of variation (CV%) of Plasticity of each cohort.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Defining Connectivity (dispersion of brain signal) coefficient of variation (CV%) in each cohort.</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Measure of the coefficient of variation (CV%) of Connectivity of each cohort.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Defining Plasticity (excitation/inhibition brain response) minimum, median, maximum in each cohort.</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Measure of the minimum, median, maximum of Plasticity of each cohort.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Defining Connectivity (dispersion of brain signal) minimum, median, maximum in each cohort.</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Measure of the minimum, median, maximum of Connectivity of each cohort.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Defining Plasticity (excitation/inhibition brain response) 95% confidence interval in each cohort.</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Measure of the 95% confidence interval of Plasticity of each cohort.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Defining Connectivity (dispersion of brain signal) 95% confidence interval in each cohort.</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Measure of the 95% confidence interval of Connectivity of each cohort.</description>
  </primary_outcome>
  <number_of_groups>13</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Healthy</condition>
  <condition>CVA</condition>
  <condition>Hemorrhage</condition>
  <condition>TBI (Traumatic Brain Injury)</condition>
  <condition>Concussion, Brain</condition>
  <condition>Fibromyalgia</condition>
  <condition>ABD</condition>
  <condition>Adhd</condition>
  <condition>Dementia</condition>
  <condition>Mci</condition>
  <condition>Cognitive Impairment</condition>
  <condition>Cognitive Decline</condition>
  <condition>MS (Multiple Sclerosis)</condition>
  <arm_group>
    <arm_group_label>healthy</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>CVA</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Hammorhage</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>TBI</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Concussion</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Fibromyalgia</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>ABD</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>ADHD</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>MCI</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>DEMENTIA</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>COGNITIVE IMPAIRMENT</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>COGNITIVE DECLINE</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>MS</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention, this is a retrospective study.</intervention_name>
    <description>No intervention, this is a retrospective study.</description>
    <arm_group_label>ABD</arm_group_label>
    <arm_group_label>ADHD</arm_group_label>
    <arm_group_label>COGNITIVE DECLINE</arm_group_label>
    <arm_group_label>COGNITIVE IMPAIRMENT</arm_group_label>
    <arm_group_label>CVA</arm_group_label>
    <arm_group_label>Concussion</arm_group_label>
    <arm_group_label>DEMENTIA</arm_group_label>
    <arm_group_label>Fibromyalgia</arm_group_label>
    <arm_group_label>Hammorhage</arm_group_label>
    <arm_group_label>MCI</arm_group_label>
    <arm_group_label>MS</arm_group_label>
    <arm_group_label>TBI</arm_group_label>
    <arm_group_label>healthy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient arriving to be treated at the Sagol center for hyperbaric medicine and research at
        Asaf-Harophe in te years of 2017-2019.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects over the age of 18.

          -  Subjects that performed at least one EEG test as a part of their hyperbaric treatment
             at Sagol center Asaf-Harophe.

        Exclusion Criteria:

          -  Subjects with no EEG test or that their EEG recording is in pure quality, not allowing
             analysis of the data.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Asaf-Harophe</name>
      <address>
        <city>Rishon LeZion</city>
        <zip>70300</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 25, 2019</study_first_submitted>
  <study_first_submitted_qc>September 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 19, 2019</study_first_posted>
  <last_update_submitted>September 18, 2019</last_update_submitted>
  <last_update_submitted_qc>September 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Brain Concussion</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

